🇺🇸 FDA
Patent

US 8710064

2-aryl-4-quinazolinones and their pharmaceutical compositions

granted A61PA61P35/00

Quick answer

US patent 8710064 (2-aryl-4-quinazolinones and their pharmaceutical compositions) held by China Medical University expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00